Event Date/Time: Mar 14, 2011 | End Date/Time: Mar 15, 2011 |
Description
Featuring 18 leading industry expert speakers, the jam packed CPD Accredited program addresses key such areas as:
Practical challenges in PhV inspections
Updates on the DSUR
New risk management activities
Signal detection and managing PhV data
All designed to provide the most complete and content driven Pharmacovigilance Summit around.
Our key Industry Leading Speakers Include
Peter Schiemann, Global Head of Quality Risk Management, Hoffmann-La Roche
Stewart Geary, Vice President, Deputy Director,
Corporate Regulatory Compliance and Quality Assurance Headquarters, Eisai
Mariska Kooijmans-Coutinho, Vice President Drug Safety and Risk Management, and QPPV, Biogen Idec
George McCormick, Vice President, Drug Safety & Disposition, Cephalon
Shelley Gandhi, Unit Manager-Signal Management GroupVigilance & Risk Management of Medicines, MHRA
Michèle Sangeleer, Medical Information & Pharmacovigilance Manager, Eli Lilly
Barbara Donner, Global Head of Safety Science Business Support, Hoffmann-La Roche
Heide Cunning, Director, Safety Operations, Ortho-Mcneil Janssen (A Johnson and Johnson Company)
Karen Pattenden, Senior Director Drug Safety & Public Health/EEA QPPV, Gilead Sciences International ltd
Patricia Bocciarelli, International Pharmacovigilance Expert Clinical Quality & Compliance, Sanofi-Aventis